New bisphosphonic acid approved by FDA.
D004164:Diphosphonates / Q000008:administration & dosage* / Q000494:pharmacology; D017277:Drug Approval; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D007093:Imidazoles / Q000008:administration & dosage* / Q000494:pharmacology; D009363:Neoplasm Proteins / Q000187:drug effects*; D009369:Neoplasms / Q000150:complications* / Q000628:therapy; D044162:Parathyroid Hormone-Related Protein; D014481:United States; D014486:United States Food and Drug Administration; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D009363:Neoplasm Proteins; C470121:PTHLH protein, human; D044162:Parathyroid Hormone-Related Protein; D000077211:Zoledronic Acid